| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $457,523 | 23 | 100 |
| Szot Matthew K | Chief Financial Officer | 0 | $0 | 1 | $69,233 | $-69,233 |
| Pham Quang X | CEO and Chairman | 0 | $0 | 22 | $388,290 | $-388,290 |
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Over the last 12 months, insiders at Cadrenal Therapeutics, Inc. Common Stock have bought $0 and sold $457,523 worth of Cadrenal Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Cadrenal Therapeutics, Inc. Common Stock have bought $147,504 and sold $549,051 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,669 shares for transaction amount of $1,842 was made by MURPHY JOHN RAYMOND (director) on 2023‑10‑05.
| 2026-06-29 | Sale | Pham Quang X | Chairman and CEO | 7,400 0.2412% | $3.03 | $22,422 | -50.00% | |
| 2026-06-26 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 9,029 0.3128% | $3.05 | $27,538 | -50.16% | |
| 2026-06-25 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 2,127 0.0725% | $3.00 | $6,381 | -46.50% | |
| 2026-06-23 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 2,277 0.0774% | $3.20 | $7,286 | -49.67% | |
| 2026-06-22 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 9,167 0.3324% | $3.55 | $32,543 | -51.42% | |
| 2026-06-17 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 513 0.0182% | $3.16 | $1,621 | -49.68% | |
| 2026-06-16 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 3,613 0.1318% | $3.18 | $11,489 | -48.36% | |
| 2026-06-15 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 3,666 0.1237% | $3.58 | $13,124 | -52.85% | |
| 2026-06-12 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 12,996 0.4825% | $3.94 | $51,204 | -57.57% | |
| 2026-06-11 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 1,462 0.0521% | $4.12 | $6,023 | -60.79% | |
| 2026-06-10 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 3,500 0.1301% | $4.21 | $14,735 | -61.59% | |
| 2026-06-09 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 12,992 0.4656% | $4.06 | $52,748 | -59.49% | |
| 2026-06-08 | Sale | Pham Quang X | Chairman, CEO and Interim CFO | 5,893 0.2138% | $4.38 | $25,811 | -61.76% | |
| 2026-06-05 | Sale | Pham Quang X | CEO and Chairman | 2,064 0.0738% | $4.42 | $9,123 | -63.40% | |
| 2026-06-04 | Sale | Pham Quang X | CEO and Chairman | 3,898 0.1391% | $4.41 | $17,190 | -61.95% | |
| 2026-06-03 | Sale | Pham Quang X | CEO and Chairman | 2,323 0.0823% | $4.26 | $9,896 | -60.02% | |
| 2026-06-02 | Sale | Pham Quang X | CEO and Chairman | 349 0.0115% | $4.46 | $1,557 | -60.69% | |
| 2026-05-29 | Sale | Pham Quang X | CEO and Chairman | 303 0.0107% | $5.01 | $1,518 | -64.72% | |
| 2026-05-28 | Sale | Pham Quang X | CEO and Chairman | 2,989 0.1028% | $4.93 | $14,736 | -64.90% | |
| 2026-05-22 | Sale | Pham Quang X | CEO and Chairman | 1,165 0.0445% | $5.69 | $6,629 | -64.55% |
| Pham Quang X | Chairman and CEO | 98589 2.7635% | $111,405.57 | 2 | 33 | <0.0001% |
| MURPHY JOHN RAYMOND | director | 614792 17.2327% | $694,714.96 | 3 | 0 | <0.0001% |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$117,515 | 16 | -27.38% | $1.66M | |
$1,246,170 | 12 | 65.67% | $5.42M | |
$24,098 | 12 | -21.64% | $1.44M |
| Increased Positions | 7 | +33.33% | 28,856 | +25.26% |
| Decreased Positions | 5 | -23.81% | 21,583 | -18.89% |
| New Positions | 3 | New | 25,685 | New |
| Sold Out Positions | 3 | Sold Out | 20,056 | Sold Out |
| Total Postitions | 23 | +9.52% | 121,516 | +6.37% |
| Vanguard Group Inc | $398.00 | 2.71% | 54,239 | +5,644 | +11.61% | 2025-09-30 |
| Citadel Advisors Llc | $146.00 | 0.99% | 19,864 | +19,864 | New | 2025-09-30 |
| Lpl Financial Llc | $104.00 | 0.71% | 14,200 | +14,200 | New | 2025-09-30 |
| Geode Capital Management, Llc | $93.00 | 0.64% | 12,710 | 0 | 0% | 2025-09-30 |
| Jpmorgan Chase & Co | $55.00 | 0.38% | 7,500 | +7,500 | New | 2025-09-30 |
| Blackrock, Inc. | $25.00 | 0.17% | 3,378 | +96 | +2.92% | 2025-09-30 |
| Morgan Stanley | $6.00 | 0.04% | 880 | +450 | +104.65% | 2025-09-30 |
| Osaic Holdings, Inc. | $4.00 | 0.03% | 500 | 0 | 0% | 2025-09-30 |
| Rockefeller Capital Management L.P. | $2.00 | 0.02% | 300 | +300 | New | 2025-09-30 |
| Jones Financial Companies Lllp | $1.00 | 0.01% | 172 | 0 | 0% | 2025-09-30 |